We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $871M
1-Year Est. Return 64.45%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
+64.45%
3 Year Est. Return
+183.15%
5 Year Est. Return
+262.44%
10 Year Est. Return
AUM
$621M
AUM Growth
+$43M
Cap. Flow
-$14.2M
Cap. Flow %
-2.29%
Top 10 Hldgs %
57.02%
Holding
70
New
1
Increased
12
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$846K
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$781K
3
DELL icon
Dell
DELL
+$763K
4
T icon
AT&T
T
+$474K
5
CSCO icon
Cisco
CSCO
+$284K

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$8.41M
2
AKAM icon
Akamai
AKAM
+$6.32M
3
SOLV icon
Solventum
SOLV
+$768K
4
INTC icon
Intel
INTC
+$409K
5
DIS icon
Walt Disney
DIS
+$315K

Sector Composition

Rank Sector Weight
1 Technology 33.57%
2 Healthcare 21.04%
3 Financials 16.24%
4 Industrials 10.59%
5 Communication Services 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$338B
$6.55M 1.06%
41,127
AWK icon
27
American Water Works
AWK
$27B
$6.28M 1.01%
45,144
-90
-0.2% -$12.9K
CRL icon
28
Charles River Laboratories
CRL
$12.5B
$5.62M 0.91%
37,064
-370
-1% -$49.3K
CLH icon
29
Clean Harbors
CLH
$16.3B
$5.58M 0.9%
24,155
-98
-0.4% -$21.5K
DHR icon
30
Danaher
DHR
$142B
$5.57M 0.9%
28,205
-50
-0.2% -$9.7K
CARR icon
31
Carrier Global
CARR
$53.2B
$4.96M 0.8%
67,744
-380
-0.6% -$25.8K
MDT icon
32
Medtronic
MDT
$110B
$4.94M 0.79%
56,621
-435
-0.8% -$36.9K
KO icon
33
Coca-Cola
KO
$375B
$4.65M 0.75%
65,698
CAT icon
34
Caterpillar
CAT
$388B
$4.53M 0.73%
11,658
-76
-0.6% -$25.3K
PYPL icon
35
PayPal
PYPL
$50.5B
$4.47M 0.72%
60,187
-1,222
-2% -$83.7K
XOM icon
36
ExxonMobil
XOM
$637B
$4.45M 0.72%
41,272
-100
-0.2% -$10.7K
GEV icon
37
GE Vernova
GEV
$264B
$3.9M 0.63%
7,368
+48
+0.7% +$20K
VRTX icon
38
Vertex Pharmaceuticals
VRTX
$125B
$3.5M 0.56%
7,855
-137
-2% -$63.1K
MRK icon
39
Merck
MRK
$317B
$3.06M 0.49%
38,670
HES
40
DELISTED
Hess
HES
$2.86M 0.46%
20,615
OTIS icon
41
Otis Worldwide
OTIS
$28.3B
$2.5M 0.4%
25,279
-1,663
-6% -$161K
PFE icon
42
Pfizer
PFE
$151B
$2.3M 0.37%
94,753
-2,544
-3% -$59.3K
DELL icon
43
Dell
DELL
$289B
$2.24M 0.36%
18,282
+7,466
+69% +$763K
ALNY icon
44
Alnylam Pharmaceuticals
ALNY
$28.9B
$2.23M 0.36%
6,824
+2,824
+71% +$781K
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$2.21M 0.36%
3,582
TXN icon
46
Texas Instruments
TXN
$260B
$2.11M 0.34%
10,160
AVGO icon
47
Broadcom
AVGO
$2.02T
$1.8M 0.29%
6,521
CMCSA icon
48
Comcast
CMCSA
$90.1B
$1.73M 0.28%
48,488
-719
-1% -$24.9K
AEM icon
49
Agnico Eagle Mines
AEM
$90.1B
$1.59M 0.26%
13,370
MRNA icon
50
Moderna
MRNA
$23B
$1.35M 0.22%
48,940
+2,998
+7% +$78.9K

Similar funds

J.P. Marvel Investment Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, J.P. Marvel Investment Advisors held 70 positions worth $621M, up 7.4% from $578M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

J.P. Marvel Investment Advisors's Q2 2025 filing shows 1 new, 12 increased, 29 reduced and 6 closed positions. Its largest new stake was Qualcomm: 5,745 shares worth $915K. The largest sale was Intra-Cellular Therapies Inc., an estimated $8.41M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • J.P. Marvel Investment Advisors's largest Q2 2025 buy was Qualcomm: 5,745 shares worth $915K.
  • J.P. Marvel Investment Advisors added most to Alnylam Pharmaceuticals in Q2 2025, an estimated $781K increase.
  • J.P. Marvel Investment Advisors's biggest Q2 2025 reduction was Eli Lilly, cutting an estimated $297K.
  • J.P. Marvel Investment Advisors fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $8.41M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 57% of its $621M portfolio in Q2 2025.
  • J.P. Marvel Investment Advisors opened 1 new position and closed 6 in Q2 2025.
  • J.P. Marvel Investment Advisors's portfolio value rose 7.4% quarter-over-quarter to $621M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.